Prediction of heart failure in patients with type 2 diabetes mellitus- a systematic review and meta-analysis
- PMID: 25686509
- DOI: 10.1016/j.diabres.2015.01.011
Prediction of heart failure in patients with type 2 diabetes mellitus- a systematic review and meta-analysis
Abstract
Background: Heart failure (HF) is a major cause of mortality and disability in type 2 diabetes mellitus (T2DM). This study sought to improve the assessment of HF risk in patients with T2DM-a step that would be critical for effective HF screening.
Methods: A systematic literature search was performed on electronic databases including MEDLINE and EMBASE, using MeSH terms 'heart failure', 'risk factor', 'T2DM', 'cardiac dysfunction', 'stage B heart failure', 'incident heart failure', 'risk assessment', 'risk impact', 'risk score', 'predictor', 'prediction' and related free text terms. The search was limited to human studies in full-length publications in English language journal from 1946 to 2014. Univariable and multivariable relative risk (RR) and hazard ratio (HR) were obtained from each study.
Results: Twenty-one studies (n=1111,569, including 507,637 subjects with T2DM) were included in this analysis with a follow-up ranging from 1 to 12 years. Associations between incident HF and risk variables described in ≥3 studies were reported. This association was greatest for insulin use (HR 2.48; 1.24-4.99), HbA1c 7.0-8.0% (2.41; 1.62-3.59), 5 years increase in age (1.47; 1.25-1.73), fasting glucose (1.28; 1.10-1.51 per standard deviation) and HbA1c (1.18; 1.14-1.23 each 1% increase). After adjustment for confounders, there were strong associations with coronary artery disease (1.77; 1.31, 2.39), HbA1c ≥ 10% (1.66; 1.45-1.89), insulin use (1.43; 1.14-1.79), HbA1c 9.0-10.0% (1.31; 1.14-1.50), fasting glucose (1.27; 1.10-1.47 per standard deviation) and 5 years increase in age (1.26; 1.13-1.40).
Conclusion: Among patients with T2DM, five common clinical variables are associated with significantly increased risk of incident HF.
Keywords: Heart failure; Predictor; Risk factors; Type 2 diabetes mellitus.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD012151. doi: 10.1002/14651858.CD012151.pub2. Cochrane Database Syst Rev. 2016. PMID: 27749986 Free PMC article.
-
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2. Cochrane Database Syst Rev. 2017. PMID: 28489279 Free PMC article.
-
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD003054. doi: 10.1002/14651858.CD003054.pub4. Cochrane Database Syst Rev. 2017. PMID: 29205264 Free PMC article.
-
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD004714. doi: 10.1002/14651858.CD004714.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2022 Apr 14;4:CD004714. doi: 10.1002/14651858.CD004714.pub4. PMID: 26545069 Free PMC article. Updated.
-
In Search of the Ideal Resistance Training Program to Improve Glycemic Control and its Indication for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Sports Med. 2016 Jan;46(1):67-77. doi: 10.1007/s40279-015-0379-7. Sports Med. 2016. PMID: 26604100
Cited by
-
Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes.Front Physiol. 2022 Apr 27;13:890907. doi: 10.3389/fphys.2022.890907. eCollection 2022. Front Physiol. 2022. PMID: 35574440 Free PMC article.
-
Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study.JACC Heart Fail. 2021 Aug;9(8):594-603. doi: 10.1016/j.jchf.2021.06.005. JACC Heart Fail. 2021. PMID: 34325890 Free PMC article.
-
Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J-DREAMS database.J Diabetes Investig. 2025 Mar;16(3):414-425. doi: 10.1111/jdi.14378. Epub 2025 Jan 24. J Diabetes Investig. 2025. PMID: 39853963 Free PMC article.
-
Type 2 diabetes and heart failure: insights from the global DISCOVER study.ESC Heart Fail. 2021 Apr;8(2):1711-1716. doi: 10.1002/ehf2.13235. Epub 2021 Feb 11. ESC Heart Fail. 2021. PMID: 33570253 Free PMC article.
-
Early Identification and Management of Heart Failure in Patients with Diabetes Mellitus in the United Arab Emirates: A Call to Action.J Saudi Heart Assoc. 2023 Aug 5;35(2):192-199. doi: 10.37616/2212-5043.1342. eCollection 2023. J Saudi Heart Assoc. 2023. PMID: 38318530 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous